EUVIMEDEUVIMED entdecken
Crossref

Advanced glycation endproduct-RAGE signaling fosters diabetic cardiomyopathy by enhancing cuproptosis and mitochondrial injury

Fengjuan Li, Yufei Zhan, Xianwu Lan, Wenxiang Huang, Bin Li, Heng Ma, Russel J. Reiter, Mohamed A. Haidara, Yuan Zhou, Yamei Xu, Xinyue Liang, Xiaoshen Zhang und 1 weitere

Metabolism and Target Organ Damage · 12.06.2026

DOI: 10.20517/mtod.2026.36 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Metabolism and Target Organ Damage, online erschienen am 12.06.2026. Verfasst von Fengjuan Li und 12 weiteren Autor:innen. Die Arbeit nennt 46 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Diabetic cardiomyopathy is characterized by altered myocardial structure and function, although the underlying mechanism remains unclear. This work evaluated the potential roles of advanced glycation end products (AGEs) and the AGE receptor (RAGE) in diabetes-evoked cardiac defects and the mechanisms involved, with a focus on cuproptosis.

Methods

C57BL/6 mice were induced with diabetes using a high-fat diet and streptozotocin. Diabetic and nondiabetic mice were treated with the RAGE blocker FPS-ZM1, followed by assessment of cardiac geometry, contractile performance, oxidative stress, apoptosis, and cuproptosis.

Results

RNA-seq analysis exhibited differentially expressed cuproptosis-related genes in diabetic hearts, implicating a cuproptosis signature. Levels of AGE and RAGE mRNA were elevated in diabetic hearts. Diabetes triggered cardiac hypertrophy, myocardial tissue fibrosis, impaired fractional shortening, ejection fraction, and cell shortening, alongside mitochondrial ultrastructural and functional defects. Diabetes promoted apoptosis (increased Bax and decreased Bcl2) and cuproptosis [copper transporter 1 (CTR1), ferredoxin 1 (FDX1), dihydrolipoamide S-acetyltransferase (DLAT), and S100 calcium-binding protein A13 (S100A13)], along with dampened Fe-S cluster proteins Aconitase 2 (ACO2) and NADH: ubiquinone oxidoreductase core subunit S8 (NDUFS8). These pathological changes were alleviated by FPS-ZM1, except for CTR1, plasma glucose, and lipid levels. Co-immunoprecipitation and domain mapping favored an interplay between RAGE and the Cu2+-binding protein S100A13. In vitro, methylglyoxal-derived AGE (MG-AGE) and high glucose levels prompted Cu2+ accumulation and/or compromised cardiomyocyte contractile function, reminiscent of in vivo diabetic cardiomyopathy. Inhibition of RAGE, cuproptosis, and S100A13 using FPS-ZM1, tetrathiomolybdate, and amlexanox, respectively, alleviated MG-AGE or high glucose-evoked Cu2+ and cardiomyocyte defects.

Conclusion

These results reveal a role for the RAGE-S100A13-cuproptosis signaling axis in AGE-driven myocardial anomalies in diabetes.

Zitieren

APA

Li, F., Zhan, Y., Lan, X., Huang, W., Li, B., Ma, H., Reiter, R. J., Haidara, M. A., Zhou, Y., Xu, Y., Liang, X., Zhang, X., & Ren, J. (2026). Advanced glycation endproduct-RAGE signaling fosters diabetic cardiomyopathy by enhancing cuproptosis and mitochondrial injury. Metabolism and Target Organ Damage. https://doi.org/10.20517/mtod.2026.36

Vancouver

Li F, Zhan Y, Lan X, Huang W, Li B, Ma H, et al. Advanced glycation endproduct-RAGE signaling fosters diabetic cardiomyopathy by enhancing cuproptosis and mitochondrial injury. Metabolism and Target Organ Damage. 2026. doi:10.20517/mtod.2026.36

BibTeX
@article{Li2026,
  author = {Li, Fengjuan and Zhan, Yufei and Lan, Xianwu and Huang, Wenxiang and Li, Bin and Ma, Heng and Reiter, Russel J. and Haidara, Mohamed A. and Zhou, Yuan and Xu, Yamei and Liang, Xinyue and Zhang, Xiaoshen and Ren, Jun},
  title = {Advanced glycation endproduct-RAGE signaling fosters diabetic cardiomyopathy by enhancing cuproptosis and mitochondrial injury},
  journal = {Metabolism and Target Organ Damage},
  year = {2026},
  doi = {10.20517/mtod.2026.36}
}
Kostenlos starten →